These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 31419296)

  • 1. Induction and Kinetics of Complement-Fixing Antibodies Against Plasmodium vivax Merozoite Surface Protein 3α and Relationship With Immunoglobulin G Subclasses and Immunoglobulin M.
    Oyong DA; Wilson DW; Barber BE; William T; Jiang J; Galinski MR; Fowkes FJI; Grigg MJ; Beeson JG; Anstey NM; Boyle MJ
    J Infect Dis; 2019 Nov; 220(12):1950-1961. PubMed ID: 31419296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naturally acquired immune responses to P. vivax merozoite surface protein 3α and merozoite surface protein 9 are associated with reduced risk of P. vivax malaria in young Papua New Guinean children.
    Stanisic DI; Javati S; Kiniboro B; Lin E; Jiang J; Singh B; Meyer EV; Siba P; Koepfli C; Felger I; Galinski MR; Mueller I
    PLoS Negl Trop Dis; 2013 Nov; 7(11):e2498. PubMed ID: 24244763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Plasmodium vivax merozoite surface protein 3 ϒ (PvMSP3 ϒ) antibodies upon natural infection.
    Kuamsab N; Putaporntip C; Kakino A; Kosuwin R; Songsaigath S; Tachibana H; Jongwutiwes S
    Sci Rep; 2024 Apr; 14(1):9595. PubMed ID: 38671033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin GM 3 23 5,13,14 phenotype is strongly associated with IgG1 antibody responses to Plasmodium vivax vaccine candidate antigens PvMSP1-19 and PvAMA-1.
    Pandey JP; Morais CG; Fontes CJ; Braga EM
    Malar J; 2010 Aug; 9():229. PubMed ID: 20696056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naturally acquired antibodies to Plasmodium vivax blood-stage vaccine candidates (PvMSP-1₁₉ and PvMSP-3α₃₅₉₋₇₉₈ and their relationship with hematological features in malaria patients from the Brazilian Amazon.
    Mourão LC; Morais CG; Bueno LL; Jimenez MC; Soares IS; Fontes CJ; Guimarães Lacerda MV; Xavier MS; Barnwell JW; Galinski MR; Braga EM
    Microbes Infect; 2012 Aug; 14(9):730-9. PubMed ID: 22445906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of the Plasmodium vivax merozoite surface protein 1 paralog in the induction of naturally acquired antibody and memory B cell responses.
    Min HMK; Changrob S; Soe PT; Han JH; Muh F; Lee SK; Chootong P; Han ET
    Malar J; 2017 Aug; 16(1):354. PubMed ID: 28854974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody responses within two leading Plasmodium vivax vaccine candidate antigens in three geographically diverse malaria-endemic regions of India.
    Kale S; Yadav CP; Rao PN; Shalini S; Eapen A; Srivasatava HC; Sharma SK; Pande V; Carlton JM; Singh OP; Mallick PK
    Malar J; 2019 Dec; 18(1):425. PubMed ID: 31842894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Naturally Acquired Antibody Responses to Two Variant Forms of Plasmodium vivax Apical Membrane Antigen-1 in Individuals Living in Areas of Low and Unstable Malaria Transmission of Iran.
    Salavatifar M; Zakeri S; Abouie Mehrizi A; Mirkhazemi S; Dinparast Djadid N
    Arch Iran Med; 2015 Dec; 18(12):834-43. PubMed ID: 26621016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired antibody responses against Plasmodium vivax infection vary with host genotype for duffy antigen receptor for chemokines (DARC).
    Maestre A; Muskus C; Duque V; Agudelo O; Liu P; Takagi A; Ntumngia FB; Adams JH; Sim KL; Hoffman SL; Corradin G; Velez ID; Wang R
    PLoS One; 2010 Jul; 5(7):e11437. PubMed ID: 20664684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of response.
    Stanisic DI; Fowkes FJ; Koinari M; Javati S; Lin E; Kiniboro B; Richards JS; Robinson LJ; Schofield L; Kazura JW; King CL; Zimmerman P; Felger I; Siba PM; Mueller I; Beeson JG
    Infect Immun; 2015 Feb; 83(2):646-60. PubMed ID: 25422270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to Plasmodium falciparum and Plasmodium vivax merozoite surface protein 5 in Indonesia: species-specific and cross-reactive responses.
    Woodberry T; Minigo G; Piera KA; Hanley JC; de Silva HD; Salwati E; Kenangalem E; Tjitra E; Coppel RL; Price RN; Anstey NM; Plebanski M
    J Infect Dis; 2008 Jul; 198(1):134-42. PubMed ID: 18471084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of naturally acquired antibody responses against the C-terminal processing products of Plasmodium vivax Merozoite Surface Protein-1 under low transmission and unstable malaria conditions in Sri Lanka.
    Wickramarachchi T; Illeperuma RJ; Perera L; Bandara S; Holm I; Longacre S; Handunnetti SM; Udagama-Randeniya PV
    Int J Parasitol; 2007 Feb; 37(2):199-208. PubMed ID: 17055511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of IgM and IgG responses to the next generation of engineered Duffy binding protein II immunogen: Strain-specific and strain-transcending immune responses over a nine-year period.
    Medeiros CMP; Moreira EUM; Pires CV; Torres LM; Guimarães LFF; Alves JRS; Lima BAS; Fontes CJF; Costa HL; Brito CFA; Sousa TN; Ntumngia FB; Adams JH; Kano FS; Carvalho LH
    PLoS One; 2020; 15(5):e0232786. PubMed ID: 32379804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naturally Acquired Antibody Responses to Plasmodium vivax and Plasmodium falciparum Merozoite Surface Protein 1 (MSP1) C-Terminal 19 kDa Domains in an Area of Unstable Malaria Transmission in Southeast Asia.
    Wang Q; Zhao Z; Zhang X; Li X; Zhu M; Li P; Yang Z; Wang Y; Yan G; Shang H; Cao Y; Fan Q; Cui L
    PLoS One; 2016; 11(3):e0151900. PubMed ID: 26999435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Antibody Screen of a Plasmodium vivax Antigen Library Identifies Novel Merozoite Proteins Associated with Clinical Protection.
    França CT; Hostetler JB; Sharma S; White MT; Lin E; Kiniboro B; Waltmann A; Darcy AW; Li Wai Suen CS; Siba P; King CL; Rayner JC; Fairhurst RM; Mueller I
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004639. PubMed ID: 27182597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral responses against the C-terminal region of merozoite surface protein 1 can be remembered for more than 30 years in persons exposed to Plasmodium vivax.
    Lim KJ; Park JW; Yeom JS; Lee YH; Yoo SB; Oh JH; Sohn MJ; Bahk YY; Kim YS
    Parasitol Res; 2004 Mar; 92(5):384-9. PubMed ID: 14745545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG antibody profile to c-terminal region of Plasmodium vivax merozoite surface protein-1 in Thai individuals exposed to malaria.
    Pitabut N; Panichakorn J; Mahakunkijcharoen Y; Hirunpetcharat C; Looareesuwan S; Khusmith S
    Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):1-7. PubMed ID: 17539238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
    Perraut R; Varela ML; Joos C; Diouf B; Sokhna C; Mbengue B; Tall A; Loucoubar C; Touré A; Mercereau-Puijalon O
    Vaccine; 2017 Dec; 35(48 Pt B):6720-6726. PubMed ID: 29042203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble recombinant merozoite surface antigen-142kDa of Plasmodium vivax: An improved diagnostic antigen for vivax malaria.
    Mirahmadi H; Fallahi S; Seyyed Tabaei SJ
    J Microbiol Methods; 2016 Apr; 123():44-50. PubMed ID: 26851675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody responses and avidity of naturally acquired anti-Plasmodium vivax Duffy binding protein (PvDBP) antibodies in individuals from an area with unstable malaria transmission.
    Zakeri S; Babaeekhou L; Mehrizi AA; Abbasi M; Djadid ND
    Am J Trop Med Hyg; 2011 Jun; 84(6):944-50. PubMed ID: 21633032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.